8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________

Form 8-K
_____________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event Reported): May 10, 2017  

United-Guardian, Inc.
(Exact Name of Registrant as Specified in Charter)

Delaware	001-10526	11-1719724
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

230 Marcus Boulevard, Hauppauge, New York 11788

(Address of Principal Executive Offices) (Zip Code)

(631) 273-0900
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
	[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company [   ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [   ]

Item 2.02. Results of Operations and Financial Condition.

On May 10, 2017, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

Exhibit 99.1. Press release dated May 10, 2017

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	United-Guardian, Inc.
Date: May 10, 2017	By:	/s/ Ken Globus
		Ken Globus
		President

EX-99 2 exh_991.htm PRESS RELEASE

EXHIBIT 99.1

United-Guardian Reports Higher First Quarter Sales and Earnings

HAUPPAUGE, N.Y., May 10, 2017 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported today that an increase in demand for its personal care and pharmaceutical products resulted in a 23% increase in sales and a 21% increase in net income for the first quarter of 2017 compared with the same quarter last year. Sales for the period increased from $2,330,576 in the first quarter of 2016 to $2,872,722 in this year’s first quarter, and net income rose from $525,091 ($0.11 per share) to $634,435 ($0.14 per share).

Ken Globus, President of United-Guardian, stated, “As a result the resumption of shipments of one of our Lubrajel^® products to China, sales of our personal care products increased by 37% in the first quarter of this year. This increase, along with a 53% increase in revenue from our pharmaceutical products (partially offset by some lower European and medical product sales), resulted in a significant increase in sales for the first quarter of 2017. The increase in pharmaceutical revenue was due to sales of our new single-dose form of Renacidin^®, our most important pharmaceutical product, which was not yet available for sale in the first quarter of 2016. We are optimistic that we will be able to continue to increase sales as we bring some of our new personal care products to market.”

United-Guardian is a manufacturer of cosmetic ingredients, personal and health care products, pharmaceuticals, and specialty industrial products.

NOTE:   This press release contains both historical and "forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements about the company’s expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the “safe harbor” provisions of that Act. Such statements are subject to a variety of factors that could cause our actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company’s business please refer to the company's reports and filings with the Securities and Exchange Commission.

RESULTS FOR THE QUARTERS ENDED MARCH 31, 2017 and MARCH 31, 2016*
STATEMENTS OF INCOME (UNAUDITED)
		THREE MONTHS ENDED    MARCH 31,
			2017			2016
	Sales:
	Gross sales	$	2,872,722		$	2,330,576
	Sales rebates and allowances		(86,334	)		(68,000	)
	Net Sales		2,786,388			2,262,576
	Costs and expenses:
	Cost of sales		1,264,096			897,725
	Operating expenses		463,480			467,556
	Research and development		189,729			177,566
	Total costs and expenses		1,917,305			1,542,847
	Income from operations		869,083			719,729
	Other income:
	Investment income		52,872			43,312
	Income before provision for                  income taxes		921,955			763,041
	Provision for income taxes		287,520			237,950
	Net income	$	634,435		$	525,091
	Earnings per common share        (Basic and Diluted)	$	0.14		$	0.11
	Weighted average shares – basic and diluted		4,594,319			4,594,319

_* Additional financial information can be found at the company’s web site at www.u-g.com.

Contact:  

Robert S. Rubinger
Public Relations
(631) 273-0900

EX-99

EdgarFiling